Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record is available, describing a completed Phase 2 study of pembrolizumab with radiation for cisplatin-ineligible patients with locally advanced head and neck cancer. It includes participant eligibility and study locations, treatment and outcome details, and a linked study protocol.SummaryDifference51%

- Check16 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide banner announces NIH updates about replacing the term “Artificial Intelligence” with “Super Intelligence” during a transition. The clinical study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe footer's site revision indicator changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating the resource is inaccessible and preventing viewing the study details on this page.SummaryDifference19%

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.